Product
BR101801
Aliases
BR101801 (Phase Ia), BR101801 (Phase Ib)
1 clinical trial
7 indications
Indication
Diffuse Large B-Cell LymphomaIndication
Follicular LymphomaIndication
Chronic Lymphocytic LeukemiaIndication
B-cell LymphomaIndication
Marginal Zone LymphomaIndication
Waldenstrom MacroglobulinemiaIndication
Peripheral T Cell LymphomaClinical trial
A Phase I, Open-label, Multi-center, Dose Escalation, and Expansion Study of BR101801 in Adult Patients With Advanced Hematologic MalignanciesStatus: Active (not recruiting), Estimated PCD: 2023-09-21